Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (151-160 of 302) with videos related to

Pageof 31
Sort By:
Plos One|January 24, 2017
High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial CancerJohn J Wallbillich, Srirama Josyula, Uksha Saini, et al.
Obstetrics and Gynecology|November 2, 2006
Improved survival with an intact DNA mismatch repair system in endometrial cancerDavid E Cohn, Wendy L Frankel, Kimberly E Resnick, et al.
The Oncologist|August 17, 2021
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?Casey M Cosgrove, Floor J Backes, David O'Malley, et al.
Gynecologic Oncology|September 26, 2022
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?Courtney J Riedinger, Jenna M Patterson, Floor J Backes, et al.
Gynecologic Oncology|June 10, 2014
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancerEric L Eisenhauer, Vanna Zanagnolo, David E Cohn, et al.
Gynecologic Oncology|December 4, 2018
Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactionsMonica Hagan Vetter, Ambar Khan, Floor J Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2015
Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology ConsultationSarah Crafton, Silpa Nekkanti, Courtney Lynch, et al.
Journal of the National Cancer Institute|September 3, 2015
Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial CancerChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Journal of Ovarian Research|December 8, 2022
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virusUksha Saini, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
Scientific Data|July 3, 2021
Profiling the small non-coding RNA transcriptome of the human placentaVictor D Martinez, David E Cohn, Nikita Telkar, et al.
Pageof 31

Showing results (151-160 of 302) with videos related to

Sort By:
Pageof 31
Plos One|January 24, 2017
High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial CancerJohn J Wallbillich, Srirama Josyula, Uksha Saini, et al.
Obstetrics and Gynecology|November 2, 2006
Improved survival with an intact DNA mismatch repair system in endometrial cancerDavid E Cohn, Wendy L Frankel, Kimberly E Resnick, et al.
The Oncologist|August 17, 2021
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?Casey M Cosgrove, Floor J Backes, David O'Malley, et al.
Gynecologic Oncology|September 26, 2022
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?Courtney J Riedinger, Jenna M Patterson, Floor J Backes, et al.
Gynecologic Oncology|June 10, 2014
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancerEric L Eisenhauer, Vanna Zanagnolo, David E Cohn, et al.
Gynecologic Oncology|December 4, 2018
Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactionsMonica Hagan Vetter, Ambar Khan, Floor J Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2015
Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology ConsultationSarah Crafton, Silpa Nekkanti, Courtney Lynch, et al.
Journal of the National Cancer Institute|September 3, 2015
Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial CancerChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Journal of Ovarian Research|December 8, 2022
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virusUksha Saini, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
Scientific Data|July 3, 2021
Profiling the small non-coding RNA transcriptome of the human placentaVictor D Martinez, David E Cohn, Nikita Telkar, et al.
Pageof 31